Lung Cancer | Oncology Today with Dr Neil Love: Role of Immune Checkpoint Inhibitors in the Management of Metastatic NSCLC without Actionable Mutations

published 6 months ago by Dr Neil Love

Featuring an interview with Dr Corey J Langer on the practical considerations in the treatment of non-small cell lung cancer without an actionable mutation. CME information and select publications

more episodes from Research To Practice | Oncology Videos